27 February 2019 - Deluge comes just as prime minister hints at delay.
The UK pharma industry is being inundated with information on how it will be asked to operate in a no-deal scenario as the Brexit process enters “unprecedented political waters,” says the BioIndustry Association (BIA).
BIA chief executive Steve Bates says in a blog post that there has been a rapid increase in no-deal planning by the government over the last month as UK politicians “continue to discuss various Brexit scenarios – and put off making key decisions.”